Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiacheng Bi

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Cellular & Molecular Immunology|January 9, 2021
CD226: a potent driver of antitumor immunity that needs to be maintainedJiacheng Bi
Cellular & Molecular Immunology|January 13, 2022
NK cell dysfunction in patients with COVID-19Jiacheng Bi
Frontiers in Immunology|January 2, 2023
Prospects for NK-based immunotherapy of chronic HBV infectionXiaomeng Jin, Jiacheng Bi
Frontiers in Immunology|July 14, 2017
NK Cell ExhaustionJiacheng Bi, Zhigang Tian
Frontiers in Immunology|October 22, 2021
Expression Regulation and Function of T-Bet in NK CellsChen Huang, Jiacheng Bi
Frontiers in Immunology|September 26, 2019
NK Cell Dysfunction and Checkpoint ImmunotherapyJiacheng Bi, Zhigang Tian
Frontiers in Immunology|August 28, 2020
Molecular Regulation of NK Cell MaturationJiacheng Bi, Xuefu Wang
Critical Reviews in Oncology/Hematology|January 24, 2026
TGF-β-mediated suppression of NK cell function and targeting strategies in tumor immunotherapyBo Wang, Jiacheng Bi
Frontiers of Medicine|September 28, 2024
Intracellular checkpoints for NK cell cancer immunotherapyYingying Huang, Zhigang Tian, Jiacheng Bi
Cellular & Molecular Immunology|January 9, 2021
Increased expression of adenosine A3 receptor in tumor-infiltrating natural killer cellsJiacheng Bi, Chaoyue Zheng, Xiaohu Zheng
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cellular & Molecular Immunology|January 9, 2021
CD226: a potent driver of antitumor immunity that needs to be maintainedJiacheng Bi
Cellular & Molecular Immunology|January 13, 2022
NK cell dysfunction in patients with COVID-19Jiacheng Bi
Frontiers in Immunology|January 2, 2023
Prospects for NK-based immunotherapy of chronic HBV infectionXiaomeng Jin, Jiacheng Bi
Frontiers in Immunology|July 14, 2017
NK Cell ExhaustionJiacheng Bi, Zhigang Tian
Frontiers in Immunology|October 22, 2021
Expression Regulation and Function of T-Bet in NK CellsChen Huang, Jiacheng Bi
Frontiers in Immunology|September 26, 2019
NK Cell Dysfunction and Checkpoint ImmunotherapyJiacheng Bi, Zhigang Tian
Frontiers in Immunology|August 28, 2020
Molecular Regulation of NK Cell MaturationJiacheng Bi, Xuefu Wang
Critical Reviews in Oncology/Hematology|January 24, 2026
TGF-β-mediated suppression of NK cell function and targeting strategies in tumor immunotherapyBo Wang, Jiacheng Bi
Frontiers of Medicine|September 28, 2024
Intracellular checkpoints for NK cell cancer immunotherapyYingying Huang, Zhigang Tian, Jiacheng Bi
Cellular & Molecular Immunology|January 9, 2021
Increased expression of adenosine A3 receptor in tumor-infiltrating natural killer cellsJiacheng Bi, Chaoyue Zheng, Xiaohu Zheng
Pageof 4